Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 53

    Renaming drug regulator CDSCO: Health ministry invites suggestions

    Renaming drug regulator CDSCO: Health ministry invites suggestions

    Ruby Khatun Khatun7 Sept 2018 1:28 PM IST
    The Drugs Technical Advisory Board (DTAB) in its 75th meeting held on January 3, 2017, had recommended renaming CDSCO as Indian Drugs Administration,...
    Ranbaxy Fiasco:  Malvinder Singh told to pay 3.5 million Singapore dollars

    Ranbaxy Fiasco: Malvinder Singh told to pay 3.5 million Singapore dollars

    Ruby Khatun Khatun6 Sept 2018 1:19 PM IST
    New Delhi: The Delhi High Court on Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million...
    Former Fortis Healthcare promoter Shivinder Singh sues brother Malvinder, ends business ties

    Former Fortis Healthcare promoter Shivinder Singh sues brother Malvinder, ends business ties

    Ruby Khatun Khatun5 Sept 2018 11:15 AM IST
    New Delhi: Former Fortis Healthcare promoter Shivinder Singh said Tuesday he has moved the National Company Law Tribunal (NCLT) against elder brother...
    Online pharmacy Netmeds raises Rs 247 crore in Series C funding

    Online pharmacy Netmeds raises Rs 247 crore in Series C funding

    Ruby Khatun Khatun4 Sept 2018 10:22 AM IST
    New Delhi: Netmeds, online pharmacy announced securing funding worth USD 35 million ( Rs 247 crore) from Daun Penh's investment holding and existing...
    Health Ministry draft rules on sale of drugs by e-pharmacy- Details

    Health Ministry draft rules on sale of drugs by e-pharmacy- Details

    Ruby Khatun Khatun3 Sept 2018 3:43 PM IST
    E-pharmacies will have to be backed by a physical facility that will provide customer support and which shall run not less than twelve hours for all...
    Pharma Giants looking to acquire Bharat Serums and Vaccines: Report

    Pharma Giants looking to acquire Bharat Serums and Vaccines: Report

    Ruby Khatun Khatun2 Sept 2018 11:59 AM IST
    MUMBAI: Several domestic firms are vying the race to by Bharat Serums and Vaccines Ltd (BSV).In order to acquire the Mumbai based vaccine maker Bharat...
    Unique Punishment: High Court asks Pharma Company to deposit Rs 1.50 crore towards Kerala Relief Fund

    Unique Punishment: High Court asks Pharma Company to deposit Rs 1.50 crore towards Kerala Relief Fund

    Ruby Khatun Khatun1 Sept 2018 12:01 PM IST
    Mumbai: The Bombay High Court has ordered a pharmaceutical company to deposit Rs 1.50 crore towards the Kerala Chief Minister's Fund for flood relief...
    SGLT2 inhibitors can lead to serious genital infection: USFDA warning

    SGLT2 inhibitors can lead to serious genital infection: USFDA warning

    Ruby Khatun Khatun31 Aug 2018 4:50 PM IST
    The SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
    Makers of the Alleged faulty Hip Implant objected to disclosure on import clearance, overruled by CIC

    Makers of the Alleged faulty Hip Implant objected to disclosure on import clearance, overruled by CIC

    Ruby Khatun Khatun30 Aug 2018 5:45 PM IST
    New Delhi: Importer of alleged faulty hip replacement systems had objected to disclosure of its compliance documents submitted to the Central Drugs...
    Why no Criminal action against Johnson and Johnson for faulty hip implants: Patients ask Nadda

    Why no Criminal action against Johnson and Johnson for faulty hip implants: Patients ask Nadda

    Ruby Khatun Khatun29 Aug 2018 3:35 PM IST
    New Delhi: A group of patients, who suffered due to alleged faulty hip replacement surgeries by a multinational firm, said that the Centre's response...
    Health Ministry deliberating report on faulty hip Implant Case: Nadda

    Health Ministry deliberating report on faulty hip Implant Case: Nadda

    Ruby Khatun Khatun28 Aug 2018 12:18 PM IST
    Recalled in Australia, but approved in India in the same monthNew Delhi: Union Health Minister JP Nadda said his ministry is holding deliberations on...
    Faulty Hip Implant Case Aftermath : Soon a Registry to track use of high-risk medical devices soon

    Faulty Hip Implant Case Aftermath : Soon a Registry to track use of high-risk medical devices soon

    Ruby Khatun Khatun27 Aug 2018 5:50 PM IST
    New Delhi: Soon a registry is going to take care of the use of medical devices which posses a high risk to the patients.TOI reports that the health...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok